Amrita Singh C.

Amrita Singh C. has a strong background in chemical biology and research. Amrita Singh currently holds the position of Senior Scientist in Chemical Biology at Frontier Medicines since October 2022. Prior to this, they worked as a Senior Research Investigator in Biology at Roivant Sciences from January 2022 to October 2022. Before joining Roivant Sciences, they were employed at FogPharma, where they held the roles of Scientist II and Scientist I in Chemical Biology between 2019 and 2021. Earlier in their career, Amrita served as a Postdoctoral Fellow at Harvard Medical School's Dana Farber Cancer Institute from 2017 to 2019. During their fellowship, they conducted research focused on identifying and studying the pathways of adaptation to oncogenic KRAS inhibition in pancreatic and lung cancer cells. Their work involved utilizing a quantitative temporal proteomics approach and exploring potential drug combinations to circumvent resistance.

Amrita Singh C. completed their education with a Ph.D. in Biochemistry & Molecular Biology from the University of Calgary, where they studied from 2010 to 2016. Prior to that, they pursued a Bachelor of Science Honors degree in Biotechnology from Manipal Academy of Higher Education. Amrita Singh attended Manipal University, Dubai Campus from 2006 to 2010 for their undergraduate studies.